{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T10:18:43Z","timestamp":1778926723465,"version":"3.51.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,8,29]],"date-time":"2009-08-29T00:00:00Z","timestamp":1251504000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Basic Res Cardiol"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1007\/s00395-009-0056-9","type":"journal-article","created":{"date-parts":[[2009,8,28]],"date-time":"2009-08-28T12:35:30Z","timestamp":1251462930000},"page":"129-137","source":"Crossref","is-referenced-by-count":14,"title":["AMP579 is revealed to be a potent A2b-adenosine receptor agonist in human 293 cells and rabbit hearts"],"prefix":"10.1007","volume":"105","author":[{"given":"Yanping","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiulan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi-Ming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheree","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karina","family":"F\u00f6rster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael V.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Krieg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James M.","family":"Downey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,8,29]]},"reference":[{"key":"56_CR1","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1023\/A:1007850527878","volume":"14","author":"GF Baxter","year":"2000","unstructured":"Baxter GF, Hale SL, Miki T, Kloner RA, Cohen MV, Downey JM, Yellon DM (2000) Adenosine A1 agonist at reperfusion trial (AART): results of a three-center, blinded, randomized, controlled experimental infarct study. Cardiovasc Drugs Ther 14:607\u2013614","journal-title":"Cardiovasc Drugs Ther"},{"key":"56_CR2","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0008-6363(00)00115-2","volume":"47","author":"JM Budde","year":"2000","unstructured":"Budde JM, Velez DA, Zhao Z-Q, Clark KL, Morris CD, Muraki S, Guyton RA, Vinten-Johansen J (2000) Comparative study of AMP579 and adenosine in inhibition of neutrophil-mediated vascular and myocardial injury during 24\u00a0h of reperfusion. Cardiovasc Res 47:294\u2013305","journal-title":"Cardiovasc Res"},{"key":"56_CR3","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00395-007-0687-7","volume":"103","author":"MV Cohen","year":"2008","unstructured":"Cohen MV, Downey JM (2008) Adenosine: trigger and mediator of cardioprotection. Basic Res Cardiol 103:203\u2013215","journal-title":"Basic Res Cardiol"},{"key":"56_CR4","doi-asserted-by":"crossref","unstructured":"de Zwart M, Link R, von Frijtag Drabbe K\u00fcnzel JK, Cristalli G, Jacobson KA, Townsend-Nicholson A, Ijzerman AP (1998) A functional screening of adenosine analogues at the adenosine A2B receptor: a search for potent agonists. Nucleosides Nucleotides 17:969\u2013985","DOI":"10.1080\/07328319808004215"},{"key":"56_CR5","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1161\/CIRCULATIONAHA.106.669697","volume":"115","author":"T Eckle","year":"2007","unstructured":"Eckle T, Krahn T, Grenz A, K\u00f6hler D, Mittelbronn M, Ledent C, Jacobson MA, Osswald H, Thompson LF, Unertl K, Eltzschig HK (2007) Cardioprotection by ecto-5\u2019-nucleotidase (CD73) and A2B adenosine receptors. Circulation 115:1581\u20131590","journal-title":"Circulation"},{"key":"56_CR6","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1161\/01.RES.77.3.611","volume":"77","author":"M Goto","year":"1995","unstructured":"Goto M, Liu Y, Yang X-M, Ardell JL, Cohen MV, Downey JM (1995) Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ Res 77:611\u2013621","journal-title":"Circ Res"},{"key":"56_CR7","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/cvr\/25.11.943","volume":"25","author":"M Goto","year":"1991","unstructured":"Goto M, Miura T, Iliodoromitis EK, O\u2019Leary EL, Ishimoto R, Yellon DM, Iimura O (1991) Adenosine infusion during early reperfusion failed to limit myocardial infarct size in a collateral deficient species. Cardiovasc Res 25:943\u2013949","journal-title":"Cardiovasc Res"},{"key":"56_CR8","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0008-6363(02)00455-8","volume":"55","author":"DJ Hausenloy","year":"2002","unstructured":"Hausenloy DJ, Maddock HL, Baxter GF, Yellon DM (2002) Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning? Cardiovasc Res 55:534\u2013543","journal-title":"Cardiovasc Res"},{"key":"56_CR9","first-page":"H971","volume":"288","author":"DJ Hausenloy","year":"2005","unstructured":"Hausenloy DJ, Tsang A, Mocanu MM, Yellon DM (2005) Ischemic preconditioning protects by activating prosurvival kinases at reperfusion. Am J Physiol 288:H971\u2013H976","journal-title":"Am J Physiol"},{"key":"56_CR10","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0022-2828(03)00043-9","volume":"35","author":"DJ Hausenloy","year":"2003","unstructured":"Hausenloy DJ, Yellon DM (2003) The mitochondrial permeability transition pore: its fundamental role in mediating cell death during ischaemia and reperfusion. J Mol Cell Cardiol 35:339\u2013341","journal-title":"J Mol Cell Cardiol"},{"key":"56_CR11","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00395-008-0736-x","volume":"103","author":"DJ Hausenloy","year":"2008","unstructured":"Hausenloy DJ, Yellon DM (2008) Clinical translation of cardioprotective strategies: report and recommendations of the Hatter Institute 5th International Workshop on Cardioprotection. Basic Res Cardiol 103:493\u2013500","journal-title":"Basic Res Cardiol"},{"key":"56_CR12","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1023\/B:CARD.0000015856.02691.fa","volume":"17","author":"A Kis","year":"2003","unstructured":"Kis A, Baxter GF, Yellon DM (2003) Limitation of myocardial reperfusion injury by AMP579, an adenosine A1\/A2A receptor agonist: role of A2A receptor and Erk1\/2. Cardiovasc Drugs Ther 17:415\u2013425","journal-title":"Cardiovasc Drugs Ther"},{"key":"56_CR13","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0002-8703(03)00172-8","volume":"146","author":"SL Kopecky","year":"2003","unstructured":"Kopecky SL, Aviles RJ, Bell MR, Lobl JK, Tipping D, Frommell G, Ramsey K, Holland AE, Midei M, Jain A, Kellett M, Gibbons RJ (2003) A randomized, double-blinded, placebo-controlled, dose-ranging study measuring the effect of an adenosine agonist on infarct size reduction in patients undergoing primary percutaneous transluminal coronary angioplasty: The ADMIRE (AmP579 Delivery for Myocardial Infarction REduction) study. Am Heart J 146:146\u2013152","journal-title":"Am Heart J"},{"key":"56_CR14","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.yjmcc.2007.05.016","volume":"43","author":"A Kuno","year":"2007","unstructured":"Kuno A, Critz SD, Cui L, Solodushko V, Yang X-M, Krahn T, Albrecht B, Philipp S, Cohen MV, Downey JM (2007) Protein kinase C protects preconditioned rabbit hearts by increasing sensitivity of adenosine A2b-dependent signaling during early reperfusion. J Mol Cell Cardiol 43:262\u2013271","journal-title":"J Mol Cell Cardiol"},{"key":"56_CR15","first-page":"H1288","volume":"295","author":"A Kuno","year":"2008","unstructured":"Kuno A, Solenkova NV, Solodushko V, Dost T, Liu Y, Yang X-M, Cohen MV, Downey JM (2008) Infarct limitation by a protein kinase G activator at reperfusion in rabbit hearts is dependent on sensitizing the heart to A2b agonists by protein kinase C. Am J Physiol 295:H1288\u2013H1295","journal-title":"Am J Physiol"},{"key":"56_CR16","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0026-895X(24)12531-X","volume":"56","author":"J Linden","year":"1999","unstructured":"Linden J, Thai T, Figler H, Jin X, Robeva AS (1999) Characterization of human A2B adenosine receptors: radioligand binding, western blotting, and coupling to Gq in human embryonic kidney 293 cells and HMC-1 mast cells. Mol Pharmacol 56:705\u2013713","journal-title":"Mol Pharmacol"},{"key":"56_CR17","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1093\/cvr\/28.7.1057","volume":"28","author":"GS Liu","year":"1994","unstructured":"Liu GS, Richards SC, Olsson RA, Mullane K, Walsh RS, Downey JM (1994) Evidence that the adenosine A3 receptor may mediate the protection afforded by preconditioning in the isolated rabbit heart. Cardiovasc Res 28:1057\u20131061","journal-title":"Cardiovasc Res"},{"key":"56_CR18","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1161\/01.CIR.84.1.350","volume":"84","author":"GS Liu","year":"1991","unstructured":"Liu GS, Thornton J, Van Winkle DM, Stanley AWH, Olsson RA, Downey JM (1991) Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart. Circulation 84:350\u2013356","journal-title":"Circulation"},{"key":"56_CR19","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/00005344-199905000-00005","volume":"33","author":"MJ McVey","year":"1999","unstructured":"McVey MJ, Smits GJ, Cox BF, Kitzen JM, Clark KL, Perrone MH (1999) Cardiovascular pharmacology of the adenosine A1\/A2-receptor agonist AMP 579: coronary hemodynamic and cardioprotective effects in the canine myocardium. J Cardiovasc Pharmacol 33:703\u2013710","journal-title":"J Cardiovasc Pharmacol"},{"key":"56_CR20","first-page":"H437","volume":"282","author":"RR Morrison","year":"2002","unstructured":"Morrison RR, Talukder MAH, Ledent C, Mustafa SJ (2002) Cardiac effects of adenosine in A2A receptor knockout hearts: uncovering A2B receptors. Am J Physiol 282:H437\u2013H444","journal-title":"Am J Physiol"},{"key":"56_CR21","volume-title":"Guide for the care and use of laboratory animals","author":"National Research Council","year":"1996","unstructured":"National Research Council (1996) Guide for the care and use of laboratory animals, 7th edn. National Academy Press, Washington, DC","edition":"7"},{"key":"56_CR22","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1476-5381.1994.tb14043.x","volume":"111","author":"M-C Peakman","year":"1994","unstructured":"Peakman M-C, Hill SJ (1994) Adenosine A2B-receptor-mediated cyclic AMP accumulation in primary rat astrocytes. Br J Pharmacol 111:191\u2013198","journal-title":"Br J Pharmacol"},{"key":"56_CR23","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.cardiores.2006.02.014","volume":"70","author":"S Philipp","year":"2006","unstructured":"Philipp S, Yang X-M, Cui L, Davis AM, Downey JM, Cohen MV (2006) Postconditioning protects rabbit hearts through a protein kinase C-adenosine A2b receptor cascade. Cardiovasc Res 70:308\u2013314","journal-title":"Cardiovasc Res"},{"key":"56_CR24","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0022-3565(24)37630-X","volume":"286","author":"GJ Smits","year":"1998","unstructured":"Smits GJ, McVey M, Cox BF, Perrone MH, Clark KL (1998) Cardioprotective effects of the novel adenosine A1\/A2 receptor agonist AMP 579 in a porcine model of myocardial infarction. J Pharmacol Exp Ther 286:611\u2013618","journal-title":"J Pharmacol Exp Ther"},{"key":"56_CR25","first-page":"H441","volume":"290","author":"NV Solenkova","year":"2006","unstructured":"Solenkova NV, Solodushko V, Cohen MV, Downey JM (2006) Endogenous adenosine protects preconditioned heart during early minutes of reperfusion by activating Akt. Am J Physiol 290:H441\u2013H449","journal-title":"Am J Physiol"},{"key":"56_CR26","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1161\/01.CIR.85.2.659","volume":"85","author":"JD Thornton","year":"1992","unstructured":"Thornton JD, Liu GS, Olsson RA, Downey JM (1992) Intravenous pretreatment with A1-selective adenosine analogues protects the heart against infarction. Circulation 85:659\u2013665","journal-title":"Circulation"},{"key":"56_CR27","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0008-6363(95)00235-9","volume":"31","author":"RS Vander Heide","year":"1996","unstructured":"Vander Heide RS, Reimer KA (1996) Effect of adenosine therapy at reperfusion on myocardial infarct size in dogs. Cardiovasc Res 31:711\u2013718","journal-title":"Cardiovasc Res"},{"key":"56_CR28","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/00005344-200109000-00016","volume":"38","author":"Z Xu","year":"2001","unstructured":"Xu Z, Downey JM, Cohen MV (2001) AMP 579 reduces contracture and limits infarction in rabbit heart by activating adenosine A2 receptors. J Cardiovasc Pharmacol 38:474\u2013481","journal-title":"J Cardiovasc Pharmacol"},{"key":"56_CR29","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/01.hdx.0000098614.29006.a7","volume":"5","author":"Z Xu","year":"2003","unstructured":"Xu Z, Downey JM, Cohen MV (2003) Timing and duration of administration are crucial for antiinfarct effect of AMP 579 infused at reperfusion in rabbit heart. Heart Dis 5:368\u2013371","journal-title":"Heart Dis"},{"key":"56_CR30","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1006\/jmcc.2000.1264","volume":"32","author":"Z Xu","year":"2000","unstructured":"Xu Z, Yang X-M, Cohen MV, Neumann T, Heusch G, Downey JM (2000) Limitation of infarct size in rabbit hearts by the novel adenosine receptor agonist AMP 579 administered at reperfusion. J Mol Cell Cardiol 32:2339\u20132347","journal-title":"J Mol Cell Cardiol"},{"key":"56_CR31","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.yjmcc.2003.12.008","volume":"36","author":"X-M Yang","year":"2004","unstructured":"Yang X-M, Krieg T, Cui L, Downey JM, Cohen MV (2004) NECA and bradykinin at reperfusion reduce infarction in rabbit hearts by signaling through PI3\u00a0K, ERK, and NO. J Mol Cell Cardiol 36:411\u2013421","journal-title":"J Mol Cell Cardiol"}],"container-title":["Basic Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00395-009-0056-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00395-009-0056-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00395-009-0056-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T22:17:49Z","timestamp":1739312269000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00395-009-0056-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,29]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["56"],"URL":"https:\/\/doi.org\/10.1007\/s00395-009-0056-9","relation":{},"ISSN":["0300-8428","1435-1803"],"issn-type":[{"value":"0300-8428","type":"print"},{"value":"1435-1803","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,29]]}}}